Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials-Reference-Cited by-同舟云学术

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Published:2010-11 Issue:9753 Volume:376 Page:1670-1681
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Publisher

Elsevier BV

Subject

General Medicine

Reference47 articles.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins;Lancet,2005

2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

3. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995

4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators;Sacks;N Engl J Med,1996

5. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts;N Engl J Med,1997

Cited by 5254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and pilot results from the Million Veteran Program Return Of Actionable Results (MVP-ROAR) Study;American Heart Journal;2024-10

2. Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry;Journal of Cardiology;2024-10

3. Impact of Implementation of a Region-Wide Low-Density Lipoprotein Cholesterol Management Clinical Pathway for the Secondary Prevention of Acute Myocardial Infarction;Circulation Journal;2024-09-14

4. Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs;Expert Opinion on Drug Metabolism & Toxicology;2024-09-13

5. Minimal Transfer of Atorvastatin and Its Metabolites in Human Milk: A Case Series;Breastfeeding Medicine;2024-09-13